According to Zacks, “Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. “
Several other analysts have also recently weighed in on the company. assumed coverage on Paragon 28 in a report on Tuesday, November 9th. They set a buy rating and a $28.00 price target for the company. JMP Securities reissued a buy rating and set a $29.00 price target on shares of Paragon 28 in a report on Tuesday, November 23rd. Needham & Company LLC reissued a buy rating and set a $31.00 price target on shares of Paragon 28 in a report on Monday, January 10th. Finally, Piper Sandler began coverage on Paragon 28 in a research note on Tuesday, November 9th. They set an overweight rating and a $30.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Buy and an average price target of $29.50.
Paragon 28 (NYSE:FNA) last released its quarterly earnings data on Monday, November 22nd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.08) by ($0.04). The firm had revenue of $35.85 million during the quarter, compared to the consensus estimate of $34.95 million. As a group, equities research analysts anticipate that Paragon 28 will post -0.25 earnings per share for the current fiscal year.
Paragon 28 Company Profile
Paragon 28 Inc is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc is based in ENGLEWOOD, Colo.
Recommended Story: How to Profit and Limit Losses With Stop Orders
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.